Aspirin

Results of the INSURE trial were unable to establish noninferiority of indobufen vs. aspirin for the secondary prevention of 90-day stroke in patients with moderate to severe ischemic stroke presenting within 72 hours of symptom onset.

Among adults without CAD, the absolute risk for major bleeding with aspirin as primary prevention therapy exceeds the any absolute MI benefits for every level of atherosclerotic CVD risk, data from a meta-analysis show.

TAMPA, Fla. — Aspirin as a thromboprophylaxis agent was noninferior to low-molecular-weight heparin for all-cause mortality in patients with extremity, pelvic or acetabular fractures.

Healio and Cardiology Today have compiled a list of the most-read news of 2022 in cardiology.

ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.

Healio and Cardiology Today have compiled a list of the most-read news of 2022 in CHD and prevention.

In people with a family history of parental premature MI, aspirin for primary prevention was not associated with reduced CV events or overall mortality, according to data published in the European Journal of Preventive Cardiology.

An aspirin de-implementation intervention appeared associated with reduced bleeding risk patients hospitalized with atrial fibrillation and/or venous thromboembolism and taking warfarin, according to data published in JAMA Network Open.

For healthy older patients, an aspirin a day does not reduce fracture risk and might increase the risk for serious falls, according to researchers.

In this episode, data show ‘critical need’ for universal genetic testing; patients with inflammatory breast cancer at high risk for brain metastases; palbociclib fails to benefit breast cancer subgroup and more.